Big pharma’s Alzheimer’s gold rush: 35 new drugs to hit the market in the next few years as the drug cartels cash in on cognitive decline.

Big pharma's Alzheimer's gold rush: 35 new drugs to hit the market in the next few years as the drug cartels cash in on cognitive decline.

Multinational corporations are literally racing against one another to be the first to release these “blockbuster” drugs, which stand to generate billions of dollars in new profits for the legal drug cartels. Alzheimer’s, it turns out, is the next big market for the pharmaceutical kingpins, which up until now have had a difficult time producing drugs that actually work and are safe. There currently 23 drugs in phase II and III trials that aim to target amyloid protein buildup in the brain, which is one believed-to-be cause of Alzheimer’s disease. Another 28 drugs are being rushed through the approval process to treat neurotransmitter activity

View Full Post

More great content like this @ Politics & World Issues Front Page or you can Request Invite

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s